These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 33124921)

  • 1. Correction to:
    Hum Gene Ther; 2020 Dec; 31(23-24):1312. PubMed ID: 33124921
    [No Abstract]   [Full Text] [Related]  

  • 2. Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors.
    Hirsch ML; Wolf SJ; Samulski RJ
    Methods Mol Biol; 2016; 1382():21-39. PubMed ID: 26611576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Toxicology of Ocular Gene Therapy with Recombinant AAV Vector rAAV.hCNGA3 in Nonhuman Primates.
    Tobias P; Philipp SI; Stylianos M; Martin B; Barbara W; Felix R; Alexander OG; Eberhart Z; Marius U; Birgit K; Sven K; Ulrich BK; Dominik FM;
    Hum Gene Ther Clin Dev; 2019 Jun; 30(2):50-56. PubMed ID: 30864850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: Song et al., Toxicology and Pharmacology of an AAV Vector Expressing Codon-Optimized RPGR in RPGR-Deficient Rd9 Mice. Hum Gene Ther Clin Dev 2018; 29(4):188-197.
    MacLaren RE; Fischer MD; De La Camara CM
    Hum Gene Ther Clin Dev; 2019 Mar; 30(1):40. PubMed ID: 30888916
    [No Abstract]   [Full Text] [Related]  

  • 5. Response to MacLaren et al., re: Toxicology and Pharmacology of an AAV Vector Expressing Codon-Optimized RPGR in RPGR-Deficient Rd9 Mice. Hum Gene Ther Clin Dev 2018;29(4):188-197.
    Ye GJ; Song C; Chulay J; Shearman M
    Hum Gene Ther Clin Dev; 2019 Mar; 30(1):41-42. PubMed ID: 30888918
    [No Abstract]   [Full Text] [Related]  

  • 6. Correction to:
    Hum Gene Ther; 2021 Feb; 32(3-4):232-233. PubMed ID: 33621143
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of the fate of rAAV genomes following in vivo administration.
    Clark KR; Penaud-Budloo M
    Methods Mol Biol; 2011; 807():239-58. PubMed ID: 22034033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction to:
    Hum Gene Ther; 2020 Oct; 31(19-20):1140. PubMed ID: 32589471
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety and Efficacy Evaluation of rAAV2tYF-PR1.7-hCNGA3 Vector Delivered by Subretinal Injection in CNGA3 Mutant Achromatopsia Sheep.
    Gootwine E; Ofri R; Banin E; Obolensky A; Averbukh E; Ezra-Elia R; Ross M; Honig H; Rosov A; Yamin E; Ye GJ; Knop DR; Robinson PM; Chulay JD; Shearman MS
    Hum Gene Ther Clin Dev; 2017 Jun; 28(2):96-107. PubMed ID: 28478700
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Hum Gene Ther; 2022 Aug; 33(15-16):840. PubMed ID: 35972328
    [No Abstract]   [Full Text] [Related]  

  • 11. Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications.
    Grieger JC; Samulski RJ
    Adv Biochem Eng Biotechnol; 2005; 99():119-45. PubMed ID: 16568890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
    Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
    Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Hum Gene Ther; 2022 Jun; 33(11-12):683-687. PubMed ID: 35648045
    [No Abstract]   [Full Text] [Related]  

  • 14. Correction to:
    Hum Gene Ther; 2021 Jul; ():. PubMed ID: 34283921
    [No Abstract]   [Full Text] [Related]  

  • 15.
    Hum Gene Ther; 2023 May; 34(9-10):471. PubMed ID: 37134199
    [No Abstract]   [Full Text] [Related]  

  • 16. Correction to:
    Hum Gene Ther; 2021 Aug; 32(15-16):864. PubMed ID: 34415183
    [No Abstract]   [Full Text] [Related]  

  • 17. U1 snRNA as an effective vector for stable expression of antisense molecules and for the inhibition of the splicing reaction.
    Martone J; De Angelis FG; Bozzoni I
    Methods Mol Biol; 2012; 867():239-57. PubMed ID: 22454066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel tools for production and purification of recombinant adenoassociated virus vectors.
    Grimm D; Kern A; Rittner K; Kleinschmidt JA
    Hum Gene Ther; 1998 Dec; 9(18):2745-60. PubMed ID: 9874273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoadsorption enables successful rAAV5-mediated repeated hepatic gene delivery in nonhuman primates.
    Salas D; Kwikkers KL; Zabaleta N; Bazo A; Petry H; van Deventer SJ; Aseguinolaza GG; Ferreira V
    Blood Adv; 2019 Sep; 3(17):2632-2641. PubMed ID: 31501158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.
    High KA
    Trans Am Clin Climatol Assoc; 2003; 114():337-51; discussion 351-2. PubMed ID: 12813929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.